share

(2-Methyl-2,4,5,7-Tetrahydropyrano[3,4-C]Pyrazol-7-Yl)Methanamine CAS NO 1422136-32-0


Unit Price:

CAS No.:1422136-32-0

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

(2-Methyl-2,4,5,7-tetrahydropyrano[3,4-c]pyrazol-7-yl)methanamine is a high-purity, advanced pharmaceutical intermediate characterized by its unique fused pyrano-pyrazole heterocyclic structure. This compound is essential for enabling the synthesis of novel, complex active pharmaceutical ingredients (APIs) with targeted therapeutic effects. It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the development of new chemical entities, particularly in areas requiring sophisticated molecular scaffolds.

Application

  • Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, especially for central nervous system (CNS) and anti-inflammatory targets.
  • Medicinal Chemistry Research: Used in high-throughput screening and structure-activity relationship (SAR) studies to explore new bioactive molecules.
  • Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and scale-up of complex organic molecules.
  • Chemical Biology: Serves as a precursor for designing molecular probes to study biological pathways and enzyme functions.
  • Agrochemical Research: Potential application in the development of new agrochemicals with novel modes of action.

Basic Information

Product Name (2-Methyl-2,4,5,7-tetrahydropyrano[3,4-c]pyrazol-7-yl)methanamine
CAS No. 1422136-32-0
Molecular Formula C9H15N3O
Molecular Weight 181.24 g/mol
Synonyms 7-(Aminomethyl)-2-methyl-2,4,5,7-tetrahydropyrano[3,4-c]pyrazole; (2-Methyl-2,4,5,7-tetrahydropyrano[3,4-c]pyrazol-7-yl)methylamine; 2-Methyl-2,4,5,7-tetrahydropyrano[3,4-c]pyrazole-7-methanamine; Pyrano[3,4-c]pyrazole-7-methanamine derivative; CAS 1422136-32-0; Fused pyrano-pyrazole amine intermediate
EINECS Contact for details

Quality Control

Every batch of (2-Methyl-2,4,5,7-tetrahydropyrano[3,4-c]pyrazol-7-yl)methanamine is manufactured under strict quality management systems. Our products undergo rigorous quality testing, including advanced chromatographic and spectroscopic methods, to ensure compliance with the high-purity standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). For long-term storage, consider keeping the material under an inert atmosphere to ensure maximum stability.

Specification

Item Specification
Appearance White to off-white solid
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 98.0%
Related Substances (HPLC) Any single impurity ≤ 0.5% Total impurities ≤ 1.5%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.